Used primarily in pharmaceutical research as a key intermediate in the synthesis of nicotinic acetylcholine receptor (nAChR) modulators. It serves as a structural building block for compounds targeting neurological disorders such as Alzheimer's disease, Parkinson's disease, and schizophrenia. Its molecular framework supports high affinity binding to specific receptor subtypes, making it valuable in developing cognitive enhancers and treatments for neuropathic pain. Also explored in the design of selective agonists and antagonists for central nervous system targets due to its favorable pharmacokinetic properties and blood-brain barrier permeability.